Price
15.16
+1.4%52W Range
Market Cap
₹5,288.16 Cr
Traded: ₹14.29 Cr (0.27%) 0.0x
Free Float: ₹2,194.58 Cr (0.65% of FF traded)
Volume · 60D trend
94.82 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +5.0% | +5.0% | +6.0% | -- | -- | Stable |
| Return | +0.0% | -2.0% | +10.0% | +9.0% | -- | Stable |
| Profit | +41.0% | +31.0% | +30.0% | -- | +39.0% | Stable |
| Sales | +37.0% | +64.0% | +61.0% | -- | +110.0% | Stable |
Quarterly Results
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,680 | 2,490 | 2,381 | 1,965 | 1,280 | 1,161 | 1,070 | 1,017 | 745 | 716 | 907 | 787 | 742 | 653 | 415 | 477 |
| Expenses | 2,580 | 2,398 | 2,286 | 1,875 | 1,209 | 1,085 | 992 | 939 | 676 | 650 | 842 | 717 | 694 | 606 | 367 | 438 |
| Operating Profit | 100 | 91 | 96 | 90 | 71 | 75 | 78 | 78 | 69 | 67 | 65 | 70 | 49 | 47 | 48 | 39 |
| OPM % | 3.7% | 3.7% | 4.0% | 4.6% | 6.0% | 6.0% | 7.0% | 8.0% | 9.0% | 9.0% | 7.0% | 9.0% | 7.0% | 7.0% | 11.0% | 8.0% |
| Other Income | 30 | 25 | 15 | 21 | 28 | 24 | 27 | 4 | 32 | 14 | 6 | 2 | 3 | 21 | 13 | 33 |
| Interest | 10 | 10 | 3 | 3 | 2 | 3 | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 |
| Depreciation | 34 | 22 | 18 | 19 | 18 | 18 | 19 | 17 | 16 | 17 | 17 | 17 | 16 | 16 | 16 | 15 |
| Profit Before Tax | 87 | 85 | 89 | 89 | 79 | 78 | 84 | 62 | 83 | 62 | 54 | 55 | 35 | 51 | 45 | 56 |
| Tax % | 2.0% | -5.0% | 10.0% | 24.0% | 26.0% | 30.0% | 24.0% | 24.0% | 17.0% | 26.0% | 21.0% | 27.0% | 28.0% | 25.0% | 21.0% | 29.0% |
| Net Profit | 85 | 89 | 80 | 68 | 58 | 55 | 64 | 47 | 69 | 46 | 43 | 41 | 25 | 38 | 35 | 40 |
| Exceptional Items | -- | -0 | -3 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Sales Growth (YoY) | 109.4% | 114.5% | 122.5% | 93.2% | 71.8% | 62.1% | 18.0% | 29.2% | 0.4% | 9.7% | 118.5% | 65.0% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 7.6% | 4.6% | 21.2% | 53.5% | 10.3% | 8.5% | 5.2% | 36.5% | 4.0% | -21.1% | 15.3% | 6.1% | 13.6% | 57.4% | -13.0% | -- |
| OP Growth (YoY) | 40.8% | 21.3% | 23.1% | 15.4% | 2.9% | 11.9% | 20.0% | 11.4% | 40.8% | 42.6% | 35.4% | 79.5% | -- | -- | -- | -- |
| OP Growth (QoQ) | 9.9% | -5.2% | 6.7% | 26.8% | -5.3% | -3.8% | 0.0% | 13.0% | 3.0% | 3.1% | -7.1% | 42.9% | 4.3% | -2.1% | 23.1% | -- |
| Profit Growth (YoY) | -- | 71.0% | 19.0% | 51.0% | -12.0% | 0.0% | 43.0% | 7.0% | 168.0% | 19.0% | 22.0% | 1.0% | 10.0% | 36.0% | 43.0% | 119.0% |
| EPS Growth (YoY) | 22.2% | 64.3% | 16.7% | 84.6% | -10.0% | 7.7% | 38.5% | 8.3% | 150.0% | 8.3% | 18.2% | 0.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -4.3% | 9.5% | -12.5% | 33.3% | 28.6% | -22.2% | 38.5% | -35.0% | 53.9% | 0.0% | 8.3% | 50.0% | -33.3% | 9.1% | -8.3% | -- |
| OP Margin | 3.7% | 3.6% | 4.0% | 4.6% | 5.5% | 6.5% | 7.3% | 7.7% | 9.3% | 9.4% | 7.2% | 8.9% | 6.6% | 7.2% | 11.6% | 8.2% |
| Net Margin | 3.2% | 3.6% | 3.4% | 3.5% | 4.5% | 4.7% | 6.0% | 4.6% | 9.3% | 6.4% | 4.7% | 5.2% | 3.4% | 5.8% | 8.4% | 8.4% |
| Material Cost % | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Employee Cost % | -- | 1.2% | 1.1% | 1.7% | 3.1% | 3.4% | 3.8% | 3.4% | 4.6% | 4.2% | 3.4% | 4.0% | 4.1% | 4.5% | 6.4% | 6.0% |
| P/S | 0.56 | 0.90 | 0.71 | 1.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 16.84 | 22.78 | 18.04 | 22.41 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.11 | 1.29 | 1.16 | 1.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Transcript of Earnings Conference Call for the quarter ended June 30, 2026.
Newspaper Advertisement - 16th Annual General Meeting through Video Conferencing /Other Audio Visual Means facility.
Audio Recording of the Investor/ Analyst Conference Call pertaining to the Financial Results for the quarter ended June 30, 2026.
Monitoring Agency Report for the quarter ended June 30, 2026.
Last & Final Reminder cum Forfeiture Notice to the holders of Partly Paid-up Equity Shares.
Statement of Deviation(s) or Variation(s) in Utilisation of Funds raised through Rights Issue for the quarter ended June 30, 2026.
Investors'' Presentation on Unaudited Financial Results for the quarter ended on June 30, 2026.
Alteration in the Capital Clause of Memorandum of Association, in connection with the Consolidation of shares.
Variation in Objects of the Rights Issue.
Update on Investment.
Outcome of Board Meeting for Unaudited (Standalone And Consolidated) Financial Results, Update - Increase in Investment limit, Scheme of Amalgamation, Variation in Objects of the Rights ....
Unaudited (Standalone and Consolidated) Financial Results for the quarter ended on June 30, 2026.
Intimation - Authorisation for setting up a payment system for Issuance and Operation of Prepaid Payment Instruments by Reserve Bank of India.
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
Intimation of Trading Window Closure.
Transcript of Earnings Conference Call for the quarter and year ended March 31, 2026.
Statement of Deviation(s) or Varition(s) in Utilisation of Funds raised through Rights Issue for the quarter ended March 31, 2026.
Statement of Deviation(s) or Varition(s) in Utilisation of Funds raised through Rights Issue for the quarter ended March 31, 2026.
Audio Recording of the Investor/ Analyst Conference Call pertaining to the Financial Results for the quarter and year ended March 31, 2026.
Investor Presentation on Audited Financial Results for the quarter and year ended on March 31, 2026.
Audited (Standalone and Consolidated) Financial Results for the quarter and year ended on March 31, 2026.
Acquisition of stake in Online PSB Loans Limited, Ratnaafin Capital Private Limited and Nueromind Technologies Private Limited.
Outcome of Board Meeting for Audited (Standalone And Consolidated) Financial Results for the quarter and year ended on March 31, 2026 and Acquisitions.
Intimation for Conference Call on Audited Financial Results for the quarter and year ended March 31, 2026.
Avenuesai Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited (Standalone and Consolidated) ....
Annual Secretarial Compliance Report for the Financial Year ended on March 31, 2026.
Monitoring Agency Report for the quarter ended March 31, 2026.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.
Intimation - Filing of Pre-Filed Draft Red Herring Prospectus by Rediff.com India Limited, a Subsidiary of our Company in relation to proposed IPO of Equity Shares.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Varini Patel & PACs
Intimation of Trading Window Closure.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajit Champaklal Mehta & PACs
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Infinium Motors Pvt Ltd & PACs
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jayshreeben Mehta & PACs
Outcome of RI Committee Meeting - Conversion of 18,50,287 Partly Paid-up Equity Shares of the Company into Fully Paid-up Equity Shares upon receipt of the Final Call Money.
Intimation - Transmission of Shares.
Outcome of Rights Issue Committee Meeting for 2nd Reminder cum Forfeiture Notice to the holders of Partly Paid-up Equity Shares.
Transcript of Earnings Conference Call for the quarter and nine months ended December 31, 2025.
Audio Recording of the Investor/ Analyst Conference Call pertaining to the Financial Results for the quarter and nine months ended December 31, 2025
Monitoring Agency Report for the quarter ended December 31, 2025.
Statement of Deviation(s) or Variation(s) in Utilisation of funds raised through Rights Issue for the quarter ended December 31, 2025.
Investors'' Presentation on Unaudited Financial Results for the quarter and nine months ended on December 31, 2025.
Disclosure under Regulation 30 (5) of the SEBI (LODR) Regulations, 2015.
Change in Website and Email id of the Company.
Amendment in the Code of Conducts and Policies of the Company.
Outcome of Board Meeting for Unaudited (Standalone And Consolidated) Financial Results and Amendment in the Code of Conducts and Policies of the Company.
Unaudited (Standalone and Consolidated) Financial Results for the quarter and nine months ended December 31, 2025
Avenuesai Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/02/2026 ,inter alia, to consider and approve Intimation for the Rights Issue Committee ....
Outcome of RI Committee Meeting - Conversion of 79,41,270 Partly Paid-up Equity Shares of the Company into Fully Paid-up Equity Shares upon receipt of the Final Call Money.
Annual Reports
10Credit Ratings
6Concalls
41Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Jan 2024
31 Jan 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Jan 2022
31 Jan 2022Oct 2021
31 Oct 2021Aug 2021
31 Aug 2021May 2021
31 May 2021May 2021
31 May 2021Feb 2021
28 Feb 2021Nov 2020
30 Nov 2020Sep 2020
30 Sept 2020Jun 2020
30 Jun 2020Jan 2020
31 Jan 2020Oct 2019
31 Oct 2019Aug 2019
31 Aug 2019May 2019
31 May 2019Feb 2019
28 Feb 2019Nov 2018
30 Nov 2018Aug 2018
31 Aug 2018May 2018
31 May 2018Feb 2018
28 Feb 2018Nov 2017
30 Nov 2017Aug 2017
31 Aug 2017May 2017
31 May 2017Feb 2017
28 Feb 2017Nov 2016
30 Nov 2016Aug 2016
31 Aug 2016May 2016
31 May 2016Held by ETFs
3 ETFs hold ccavenue · sorted by weight
Held by Mutual Funds
4 schemes hold ccavenue · sorted by weight